Pasadena-based Innova Medical Group to Expand COVID-19 Rapid Test Manufacturing Capacity With Acquisition of MPS Medical Inc.

Pasadena-based Innova Medical Group significantly expanded its COVID-19 rapid antigen test kit manufacturing capacity through the acquisition of MPS Medical, Inc., an FDA registered medical device manufacturer that has been producing high-quality medical devices for domestic and international customers since 2014.

Based in Brea, MPS Medical has an initial production capacity of more than 700,000 SARS-CoV-2 antigen rapid test kits per shift, immediately increasing Innova’s global production capacity of the rapid antigen test kits to nearly 9 million units a day. 

“We are excited to be part of the fast-growing Innova Medical family and to participate directly in helping the people in the U.S. and other countries to better combat the COVID-19 pandemic,” said Barry Kazemi, CEO of MPS Medical Inc., in a prepared statement.

“The acquisition of California-based MPS Medical is a testament of our commitment to making top-quality products locally in the US for domestic and international markets,” said Daniel Elliott, president, and CEO of Innova Medical Group. The company is headquartered in Pasadena Towers, located in the city’s Playhouse District. 

“With Innova’s deep expertise in COVID testing and business strategy, MPS Medical will continue to excel as a manufacturer of not only our best-in-class antigen test kits for COVID-19 but also other innovative medical products post-pandemic,” said Elliott.

The largest supplier globally for rapid COVID testing, Innova delivered more than 220 million COVID-19 test kits to over 20 countries in the last quarter of 2020, including the United Kingdom, where Innova tests are used as a COVID screening tool. Currently, Innova Medical is under contract to deliver millions of additional test kits globally, some of which will now come from the MPS Medical production site in Brea. 

As a leading COVID testing solution provider, Innova recently acquired California-based Biological Laboratory Inc., a Clinical Laboratory Improvement Amendments (CLIA)-certified clinical laboratory with more than 130 employees providing COVID testing services in Los Angeles County. 

In addition, Innova partners with Ashfield Healthcare to provide consulting and implementation services to governments and corporations. Innova is also deploying the QMC HealthIDtm App that enables patients and organizations to track and report their COVID test status in a secure and contact-less way.